EFNS task force - Therapy of nystagmus and oscillopsia

European Journal of Neurology

Volumn 11, Issue 2, 2004, Pages 83-89

  Straube, A ^a,i   Leigh, R J ^b   Bronstein, A ^c   Heide, W ^d   Riordan Eva, P ^e   Tijssen, C C ^f   Dehaene, I ^g   Straumann, D ^h  

^a UNIVERSITY OF MUNICH   (Germany)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF LÜBECK   (Germany)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

^f CPRLab   (Netherlands)

^g Department of Neurology   (Belgium)

^h UNIVERSITY OF ZURICH   (Switzerland)

ⁱ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Etiology; Nystagmus; Ocular motor disorders; Opsoclonus; Oscillopsia; Saceades; Treatment

Indexed keywords

3,4 DIAMINOPYRIDINE; ALCOHOL; ANTICONVULSIVE AGENT; BACLOFEN; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIPERIDEN; CANNABIS; CARBAMAZEPINE; CLONAZEPAM; GABAPENTIN; IMMUNOGLOBULIN; ISONIAZID; LAMOTRIGINE; LIDOCAINE; MEMANTINE; MEXILETINE; NITRAZEPAM; PHENOTHIAZINE DERIVATIVE; PHENYTOIN; PHYSOSTIGMINE; PREDNISOLONE; PROPRANOLOL; SCOPOLAMINE; THIAMINE; TRIDIHEXETHYL CHLORIDE; TRIHEXYPHENIDYL; VALPROIC ACID; VIGABATRIN;

ALCOHOL CONSUMPTION; CLINICAL TRIAL; DECOMPRESSION SURGERY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; EYE DISEASE; EYE MOVEMENT CONTROL; FOLLOW UP; HUMAN; LOW DRUG DOSE; MYOKYMIA; NONHUMAN; NYSTAGMUS; OPSOCLONUS; OSCILLOPSIA; PATCH CLAMP; PRIORITY JOURNAL; REVIEW; SACCADIC EYE MOVEMENT; SIDE EFFECT; SLOW RELEASE FORMULATION; SUPERIOR OBLIQUE MUSCLE;

ADVISORY COMMITTEES; ANIMALS; ANTICONVULSANTS; EUROPE; GABA AGONISTS; HUMANS; NYSTAGMUS, PATHOLOGIC; OCULOMOTOR NERVE DISEASES;

EID: 1242314829     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2003.00754.x     Document Type: Review

References (74)

1. Averbuch-Heller L, Tusa RJ, Fuhry L et al. (1997). A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 41:818-825.
2. Baloh RW, Spooner JW (1981). Downbeat nystagmus. A type of central vestibular nystagmus. Neurology 31:304-310.
3. Bandini F, Castello E, Mazzella L, Mancardi GL, Solaro C (2001). Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: How valid is the GABAergic hypothesis? J Neurol Neurosurg Psychiatry 71:107-110.
4. Barton JJS, Huaman AG, Sharpe JA (1994). Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: a double-blind, randomized trial of three intravenous drugs. Ann Neurol 35:319-325.
5. Bibby K, Deane JS, Farnworth D, Cappin J (1994). Superior oblique myokymia - a topical solution? Br J Ophthalmol 78:882.
6. Brandt T (1999). Vertigo. Its Multisensory Syndromes, 2nd edn. Springer-Verlag, London.
7. Brandt T, Dieterich M (1994). Vestibular paroxysmia: vascular compression of the eighth nerve? Lancet 26:798-799.
8. Brazis PW, Miller NR, Henderer JD, Lee AG (1994). The natural history and results of treatment of superior oblique myokymia. Arch Ophthalmol 112:1063-1067.
9. Bronstein AM, Miller DH, Rudge P, Kendall BE (1987). Down beating nystagmus: magnetic resonance imaging and neuro-otological findings. J Neurol Sci 81:173-184.
10. Büchele W, Brandt T, Degner D (1983). Ataxia and oscillopsia in downbeat-nystagmus vertigo syndrome. Adv Oto-Rhino Laryngol 30:291-297.
11. Carlow TJ (1986). Medical treatment of nystagmus and ocular motor disorders. Int Ophthalmol Clin 26:251-264.
12. Cross SA, Smith JL, Norton EW (1982). Periodic alternating nystagmus clearing after vitrectomy. J Clin Neuroophthalmol 2:5-11.
13. Currie J, Matsuo V (1986). The use of clonazepam in the treatment of nystagmus induced oscillopsia. Ophthalmology 93:924-932.
14. Das VE, Oruganti P, Kramer PD, Leigh RJ (2000). Experimental tests of a neural-network model for ocular oscillations caused by disease of central myelin. Exp Brain Res 133:189-197.
15. De Ridder D, Moller A, Verlooy J, Cornelissen M, De Ridder L (2002). Is the root entry/exit zone important in microvascular compression syndromes? Neurosurgery 51:427-433.
16. Dell'Osso LF (2000). Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis. Neurology 13:2190-2191.
17. Dieterich M, Straube A, Brandt T, Paulus W, Büttner U (1991). The effects of baclofen and cholinergic drugs on upbeat and downbeat nsytagmus. J Neurol Neurosurg Psychiatry 54:627-632.
18. Ell J, Gresty M, Chambers BR, Frindley L (1982). Acquired pendular nystagmus: characteristics, pathophysiology and pharmacological modification. In: Roucoux A, Crommeilinck M, eds. Physiological and Pathological Aspects of Eye Movements. Dr W. Junk Publ., The Hague, Boston, and London, pp. 89-98.
19. Endres M, Heide W, Kompf D (1996). See-saw nystagmus. Clinical aspects, diagnosis, pathophysiology: observations in 2 patients. Nervenarzt 67:484-489.
20. Fisher A, Gresty M, Chambers B, Rudge P (1983). Primary position upbeating nystagmus: a variety of central positional nystagmus. Brain 106:949-964.
21. Frisèn L, Wikkelso C (1986). Posttraumatic seesaw nystagmus abolished by ethanol ingestion. Neurology 36:841-844.
22. Furman JMR, Wall C, Pang D (1990). Vestibular function in periodic alternating nystagmus. Brain 113:1425-1439.
23. Glasauer S, Hoshi M, Kempermann U, Eggert T, Büttner U (2003). Three-dimensional eye position and slow phase velocity in humans with downbeat nystagmus. J Neurophysiol 89:338-354.
24. Gresty M, Ell JJ, Findley LJ (1982). Acquired pendular nystagmus: its characteristics, localising value and pathophysiology. J Neurol Neurosurg Psychiatry 45:431-439.
25. Halmagyi MG, Rudge P, Gresty MA (1980). Treatment of periodic alternating nystagmus. Ann Neurol 8:609-611.
26. Halmagyi MG, Rudge P, Gresty MA, Sanders MD (1983). Downbeating nystagmus. A review of 62 cases. Arch Neurol 40:777-784.
27. Halmagyi GM, Aw ST, Dehaene I, Curthoys IS, Todd MJ (1994). Jerk-waveform see-saw nystagmus due to unilateral meso-diencephalic lesion. Brain 117:775-788.
28. Hashimoto M, Ohtsuka K, Hoyt WF (2001). Vascular compression as a cause of superior oblique myokymia disclosed by thin-slice magnetic resonance imaging. Am J Ophthalmol 31:676-677.
29. Herishanu Y, Louzoun Z (1986). Trihexyphenidyl treatment of vertical pendular nystagmus. Neurology 36:82-84.
30. Hilgers R-D (2001) Qualitätsbeurteilung von Studien zur klinischen Effektivität, In: Lauterbach KW, Schrappe M, eds. Gesundheitsökonomie, Qualitätsmanagement und Evidence-based Medicine. Schattauer, Stuttgart, pp. 89-95.
31. Hoyt WF, Keane JR (1962). Superior oblique myokymia: report and discussion of five cases of benign intermittent uniocular microtremor. Arch Ophthalmol 84:461-467.
32. Isago H, Tsuboya R, Kataura A (1985). A case of periodic alternating nystagmus: with special reference to the efficacy of baclofen treatment. Auris Nasus Larynx 12:15-21.
33. Jabbari B, Rosenberg M, Scherokman B, Gunderson CH, McBurney JW, McClintock W (1987). Effectiveness of trihexyphenidyl against pendular nystagmus and palatal myoclonus: evidence of cholinergic dysfunction. Mov Disord 2:93-98.
34. Jannetta PJ, Møller MD, Møller AR (1984). Disabling positional vertigo. N Engl J Med 310:1700-1705.
35. Jay WM, Williams BB, De Chicchis A (1985). Periodic alternating nystagmus clearing after cataract surgery. J Clin Neuroophthalmol 5:149-152.
36. Kim JI, Averbuch-Heller L, Leigh RJ (2001). Evaluation of transdermal scopolamine as treatment for acquired nystagmus. J Neuro-ophthalmology 21:188-192.
37. Larmande P, Larmande A (1983). Action du baclofene sur le nystagmus alternant periodique. Bull Mem Soc Fr Ophtalmol 94:390-393.
38. Lee JP (1984). Superior oblique myokymia: a possible etiologic factor. Arch Ophthalmol 102:1178-1179.
39. Leigh RJ, Zee DS (1999). The Neurology of Eye Movements, 3rd edn. Oxford University Press, New York.
40. Leigh RJ, Burnstine TH, Ruff RL, Kasmer RJ (1991a). The effect of anticholinergic agents upon acquired nystagmus: a double-blind study of trihexyphenidyl and tridihexethyl chloride. Neurology 41:1737-1741.
41. Leigh RJ, Tomsak RL, Seidman SH, Dell'Osso LF (1991b). Superior oblique myokymia. Quantitative characteristics of the eye movements in three patients. Arch Ophthalmol 109:1710-1713.
42. Leigh RJ, Tomsak RL, Grant MP et al. (1992). Effectiveness of botulinum toxin administered to abolish acquired nystagmus. Ann Neurol 32:633-642.
43. Leigh RJ, Averbuch-Heller L, Tomsak RL, Remler BF, Yaniglos SS, Dell'Osso LF (1994). Treatment of abnormal eye movements that impair vision: strategies based on current concepts of physiology and pharmacology. Ann Neurol 36:129-141.
44. Leopold HC (1985). Opsoklonus-und Myoklonie-Syndrom. Klinische und elektronystagmographische Befunde mit Verlaufsstudien. Fortschritte der Neurologie, Psychiatrie 53:42-54.
45. Lepore FE (1987). Ethanol-induced resolution of pathologic nystagmus. Neurology 37:877.
46. Lopez LI, Bronstein AM, Gresty MA, Du Boulay EP, Rudge P (1996). Clinical and MRI correlates in 27 patients with acquired pendular nystagmus. Brain 119:465-472.
47. Marti S, Palla A, Straumann D (2002). Gravity dependence of ocular drift in patients with cerebellar downbeat nystagmus. Ann Neurol 52:712-721.
48. Mossman SS, Bronstein AM, Rudge P, Gresty MA (1993). Acquired pendular nystagmus suppressed by alcohol. Neuro-ophthalmology 13:99-106.
49. Nathanson M, Bergman PS, Bender MB (1953). Visual disturbances as the result of nystagmus on direct forward gaze. Effect of amobarbital sodium. Arch Neurol Psychiatry 69:427-435.
50. Nausieda PA, Tanner CM, Weiner WJ (1981). Opsoclonic cerebellopathy. A paraneoplastic syndrome responsive to thiamine. Arch Neurol 38:780-782.
51. Nuti D, Ciacci G, Giannini F, Rossi A, Frederico A (1986). Aperiodic alternating nystagmus: report of two cases and treatment by baclofen. Ital J Neurol Sci 7:453-459.
52. Palmer EA, Shults WT (1984). Superior oblique myokymia: preliminary results of surgical treatment. J Pediatr Ophthalmol (Strabismus) 21:91-101.
53. Pedersen RA, Troost BT, Abel LA, Zorub D (1980). Intermittent down beat nystagmus and oscillopsia reversed by suboccipital craniectomy. Neurology 30:1232-1242.
54. Pless M, Ronthal M (1996). Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin. Neurology 46:583-584.
55. Rambold H, Helmchen C, Büttner U (1999). Unilateral muscimol inactivations of the interstitial nucleus of Cajal in the alert rhesus monkey do not elicit seesaw nystagmus. Neurosci Lett 272:75-78.
56. Ridley A, Kennard C, Scholtz CL, Büttner-Ennever JA, Summers B, Turnbull A (1987). Omnipause neurons in two cases of opsoclonus associated with oat cell carcinoma of the lung. Brain 110:1699-1709.
57. Rosenberg MI, Glaser JS (1983). Superior oblique myokymia. Ann Neurol 13:667-669.
58. Samii M, Rosahl SK, Carvalho GA, Krzizok T (1998). Microvascular decompression for superior oblique myokymia: first experience. J Neurosurg 89:1020-1024.
59. Scharwey K, Krzizok T, Samii M, Rosahl SK, Kaufmann H (2000). Remission of superior oblique myokymia after microvascular decompression. Ophthalmologica 214:426-428.
60. Schon F, Hart PE, Hodgson TL et al. (1999). Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis. Neurology 53:2209-2210.
61. Spooner JW, Baloh RW (1981). Arnold-Chiari malformation. Improvement in eye movements after surgical treatment. Brain 104:51-60.
62. Stahl JS, Averbuch-Heller L, Leigh RJ (2000). Acquired nystagmus. Arch Ophthalmol 118:544-549.
63. Starck M, Albrecht H, Pöllmann W, Straube A, Dieterich M (1997). Drug therapy of acquired nystagmus in multiple sclerosis. J Neurol 244:9-16.
64. Straube A, Büttner U, Brandt T (1994). Recurrent attacks with skew deviation, torsional nystagmus and contraction of the left frontalis muscle. Neurology 44:177-178.
65. Strupp M, Schüler O (2002). Improvement of downbeat nystagmus and postural imbalance by 3,4-diaminopyridine, a prospective, placebo-controlled study. J Vestibular Res 11:226.
66. Strupp M, Schüler O, Krafczyk S et al. (2003). Treatment of downbeat nystagmus with 3,4-diaminopyridine - a prospective, placebo-controlled, double-blind study. Neurology 61:165-170.
67. Susac JO, Smith JL, Schatz NJ (1973). Superior oblique myokymia. Arch Neurol 29:432-434.
68. Tomsak RL, Kosmorsky GA, Leigh RJ (2002). Gabapentin attenuates superior oblique myokymia. Am J Ophthalmol 133:721-723.
69. Traccis S, Rosati G, Monaco MF, Aiello IN, Agnetti V (1990). Successful treatment of acquired pendular elliptical nystagmus in multiple sclerosis with isoniazid and base-out prisms. Neurology 40:492-494.
70. Traccis S, Marras MA, Puliga MV et al. (1997). Square-wave jerks and square-wave oscillations: treatment with valproic acid. Neuro-ophthalmology 18:51-58.
71. Tyler RD, Ruiz RS (1990). Propranolol in the treatment of superior oblique myokymia. Arch Ophthalmol 108:175-176.
72. Waespe W, Cohen B, Raphan T (1985). Dynamic modification of the vestibuloocular reflex by the nodulus and uvula. Science 228:199-202.
73. Yousry I, Dieterich M, Naidich TP, Schmid UD, Yousry TA (2002). Superior oblique myokymia: magnetic resonance imaging support for the neurovascular compression hypothesis. Ann Neurol 51:361-368.
74. Zee DS (1985). Mechanisms of nystagmus. Am J Otolaryngol (Suppl.):30-34.